Results 131 to 140 of about 23,536 (264)

Univariate analyses for factors associated with skin rash after initiation of nNRTI-containing regimens within the first 4 weeks.

, 2017
Univariate analyses for factors associated with skin rash after initiation of nNRTI-containing regimens within the first 4 weeks.
Chien-Yu Cheng (527602), Yi-Chien Lee (625181), Hsin-Yun Sun (61134), Mao-Song Tsai (523496), De-Yu Lin (3769525), Ning-Chi Wang (511973), Pei-Ying Wu (527605), Chien-Ching Hung (61132), Chun-Eng Liu (295105), Yi-Chieh Lee (813489), Chia-Jui Yang (527603), Shu-Hsing Cheng (450825), Hung-Jen Tang (533197), Shih-Ping Lin (3769528)   +13 more
core   +1 more source

Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study

Journal of the International Association of Providers of AIDS Care
Background Real-world comparisons of initial antiretroviral third-drug classes are limited in middle-income settings. We evaluated whether the initial third-drug class predicts time to loss of virologic suppression in Colombia.
Juan Carlos Alzate-Ángel MD, MSc, PhD, Otto Sussmann MD, BSc, Javier Andrade MD, MSc, Beatriz Hernández BSN, RN, Héctor Mueses-Marín BSc, MSc, Ximena Galindo MD, MSc, Sandra Liliana Valderrama-Beltrán MD, MSc, PhD, William Lenis MD, Leonardo Montero MD, MSc, Mónica Mantilla MD, MSc, Leonardo Arévalo MD, MSc, Diana Alzamora BSN, RN, Eric Delgado MD, MSc, Martha García MD, Ernesto Martínez-Buitrago MD,   +15 more
doaj   +1 more source

Kaplan-Meier estimates of risk for NNRTI-related skin rash according to WHO clinical stage at baseline.

, 2014
Kaplan-Meier estimates of risk for NNRTI-related skin rash according to WHO clinical stage at baseline.
Fred Stephen Sarfo (139071), Betty Norman (550971), Richard Phillips (205457), Maame Anima Sarfo (550970), David Chadwick (300132)   +4 more
core   +1 more source

Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.

PLoS ONE, 2017
ObjectivesTwo nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) plus 1 non-NRTI (nNRTI) remain the preferred or alternative combination antiretroviral therapy (cART) for antiretroviral-naive HIV-positive patients in Taiwan.
Pei-Ying Wu, Chien-Yu Cheng, Chun-Eng Liu, Yi-Chien Lee, Chia-Jui Yang, Mao-Song Tsai, Shu-Hsing Cheng, Shih-Ping Lin, De-Yu Lin, Ning-Chi Wang, Yi-Chieh Lee, Hsin-Yun Sun, Hung-Jen Tang, Chien-Ching Hung   +13 more
doaj   +1 more source

Risk factors for subtherapeutic NNRTI levels in 106 HIV positive Malawian Adults on Cart.

, 2014
NNRTI: Non-nucleoside reverse transcriptase inhibitor, cART: combination anti-retroviral therapy, EFV: efavirenz, MND: mild neurocognitive disorder, HAD: HIV associated dementia, OR: Odds ratio, CI: confidence interval, min: minimum, max: maximum.
Theresa J. Allain (244077), Laura Benjamin (388513), Joep J. van Oosterhout (244071), Robert C. Stewart (451480), Saye Khoo (575924), Tom Solomon (213007), Christine M. Kelly (575921), Kevin R. Robertson (575923), Chisomo Ngwalo (575922)   +8 more
core   +1 more source

Trends in Serum Amylase Levels in People Living with HIV: A Comparison Between INSTI and NNRTI/PI-Based Regimens

Viruses
Background: Antiretroviral therapy (ART) has transformed HIV into a chronic manageable condition, yet metabolic toxicities including pancreatic enzyme alterations remain concerns.
Elena Rabinovich, Ramon Cohen, Shay Nemet, Haitham Abu Khadija, Shira Bezalel-Rosenberg, Ilan Asher, Keren Mahlab-Guri, Daniel Elbirt   +7 more
doaj   +1 more source

Probabilistic sensitivity analysis: cost-effectiveness acceptability curve for 2NRTI+NNRTI compared with 2NRTI+IP/r as initial antiretroviral therapy.

, 2013
Probabilistic sensitivity analysis: cost-effectiveness acceptability curve for 2NRTI+NNRTI compared with 2NRTI+IP/r as initial antiretroviral therapy.
Filipa Aragão (307309), José Vera (307310), Inês Vaz Pinto (307312)   +2 more
core   +1 more source

Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients

, 2009
Background: The incidence of oral lesions related to human immunodeficiency virus (HIV) infection have been investigated after treatment with highly active antiretroviral therapy (HAART) including protease inhibitors (PI) but no data are available on the
ORTEGA, Karem L., VALE, Daniela A., MAGALHAES, Marina H. C. G.   +2 more
core  

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.

, 2015
OBJECTIVES It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART.
Ceccherini-Silberstein, Francesca, Michalik, Claudia, Kouyos, Roger D, Günthard, Huldrych F, Metzner, Karin J, Furrer, Hansjakob, Cozzi-Lepri, Alessandro, Castro, Erika, Schuurman, Rob, Aitken, Sue, Booth, Clare L, Paredes, Roger, Kaiser, Rolf, Brun-Vezinet, Francoise, Noguera-Julian, Marc, Jansen, Klaus, Di Giallonardo, Francesca, Schultze, Anna, Geretti, Anna Maria, Masquelier, Bernard, Däumer, Martin, Bellecave, Pantxika, D'Arminio Monforte, Antonella   +22 more
core   +1 more source

Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil

Memorias do Instituto Oswaldo Cruz, 2007
This study aimed to analyze human immunodeficiency virus (HIV) mutation profiles related to antiretroviral resistance following therapeutic failure, and the distribution of hiv subtypes in the Northeast Region of Brazil. A total of 576 blood samples from
Ana Maria Salustiano Cavalcanti, Heloisa Ramos Lacerda, Ana Maria de Brito, Sirleide Pereira, Daniela Medeiros, Suelene Oliveira   +5 more
doaj